Committed to improve global specialty biologics drug supply.

Specialty biologics are generally known as therapeutic proteins, used for the treatment of complex, chronic or rare diseases. They are manufactured employing complicated biotechnological processes, require professional administration support, and are often characterized by limited availabilities and high treatment costs requiring patient co-payments.

Valerius Biopharma AG is a biopharmaceutical company that has been founded to provide interchangeable treatment options for high-priced biologics, by developing specialty biosimilars. Our interdisciplinary team of experts combines decades of experience gained in the biotechnology and biosimilar industry. Excellent process science, deep knowledge and understanding of proteins with their underlying complexity, as well as profound clinical and regulatory expertise, are key factors of our success.

Together, we are committed to make the treatment of severe and life-threatening diseases more affordable for all patients worldwide.